InnoPharmax Inc. (TPEX:4172)
Taiwan
· Delayed Price · Currency is TWD 14.65
-0.20 (-1.35%)
Apr 29, 2026, 1:53 PM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.58 billion as of April 28, 2026. Its market cap has increased by 3.53% in one year.
Market Cap
1.58B
Enterprise Value
1.44B
Revenue
68.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.65
Market Cap Chart
Since September 13, 2012, InnoPharmax's market cap has increased from 1.54B to 1.58B, an increase of 2.22%. That is a compound annual growth rate of 0.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.58B |
| Tien Liang BioTech | 1.75B |
| TSH Biopharm Corporation | 1.96B |
| Winston Medical Supply | 1.31B |
| DV Biomed | 1.21B |
| Excelsior Biopharma | 1.18B |
| Johnson Chemical Pharmaceutical Works | 2.41B |
| PhytoHealth | 2.47B |